Validation of a Smartphone App for Anemia Screening Among General Population
NCT05490823 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2022-08-08
Summary
The current standard for anemia screening, complete blood count, presents invasiveness, infrastructure requirements and high costs, leading to serious underestimation of anemia prevalence and insufficient care for anemia patients. Here, the investigators established and validated an artificial intelligence system to achieve automatic detection of anemia based on patient-sourced images of fingernails and conjunctivae. This system has been integrated into a smartphone app to be further validated through hospital-based and population-based clinical trials.
Conditions
Interventions
- DEVICE
-
A smartphone app for anemia screening
This app can achieve automatic detection of anemia based on patient-sourced images of fingernails and conjunctivae.
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 87 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2022-12-01
- Completion
- 2022-12-01
Countries
- China
Study Locations
More Related Trials
-
Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
NCT04815603 ·Status: WITHDRAWN ·Phase: PHASE2
-
Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
NCT00954486 ·Status: WITHDRAWN ·Phase: NA
-
Roxadustat for Anemia in Patients With CKD
NCT04502537 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy
NCT00270270 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis
NCT02403362 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
NCT00236977 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
NCT02586402 ·Status: UNKNOWN ·Phase: PHASE2
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255437 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.
NCT04470063 ·Status: UNKNOWN ·Phase: PHASE1
-
Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)
NCT01017627 ·Status: UNKNOWN ·Phase: NA
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255424 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
NCT06080555 ·Status: COMPLETED ·Phase: PHASE1
-
VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
NCT00317239 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
NCT00236964 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
NCT02988973 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy
NCT00270283 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
NCT06932471 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients
NCT04134026 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease
NCT00270010 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia.
NCT02754999 ·Status: COMPLETED ·Phase: PHASE1
-
CKD-11101 Phase 3 SC Study
NCT03431623 ·Status: COMPLETED ·Phase: PHASE3
-
ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
NCT01964196 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis
NCT02366325 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
NCT01888445 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
NCT02829320 ·Status: COMPLETED ·Phase: PHASE3